Bio Path reported $-0.4 in EPS Earnings Per Share for its fiscal quarter ending in March of 2025.





Eps Change Date
Alterity Therapeutics Limited AUD 0 0 Dec/2023
Baxter International USD 0.44 0.25 Dec/2025
Bio Path USD -0.4 0.33 Mar/2025
Cipla INR 15.2 1.52 Dec/2025
Clal Biotechnology ILS -0.04 0.1 Dec/2022
Compugen USD -0.08 0 Sep/2025
CSL USD 5.07 3 Dec/2025
Grifols EUR 0.29 0.03 Mar/2026
Karyopharm Therapeutics USD -0.15 0.11 Dec/2024